Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | GLOBUS MED INC | — | 468,922.0 | $37.0M | 1.28% | -261K | -35.7% | $79.01 | — |
| 22 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 1,168,738.0 | $36.0M | 1.24% | +717K | +158.6% | $30.83 | -0.2% |
| 23 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,628,039.0 | $35.6M | 1.23% | -99K | -5.7% | $21.86 | -8.1% |
| 24 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 1,465,163.0 | $35.5M | 1.23% | +527K | +56.2% | $24.26 | +10.1% |
| 25 | LEGN | LEGEND BIOTECH CORP | Healthcare | 1,205,000.0 | $34.8M | 1.20% | NEW | — | $28.88 | -28.4% |
| 26 | JBIO | JADE BIOSCIENCES INC | Healthcare | 1,550,690.0 | $34.5M | 1.19% | +754K | +94.6% | $22.22 | -4.0% |
| 27 | UNH | UNITEDHEALTH GROUP INC | Healthcare | 80,000.0 | $33.3M | 1.15% | NEW | — | $415.63 | -3.5% |
| 28 | — | AVALO THERAPEUTICS INC | — | 1,654,978.0 | $30.6M | 1.05% | +1.2M | +274.4% | $18.48 | — |
| 29 | URGN | UROGEN PHARMA LTD | Healthcare | 829,810.0 | $30.5M | 1.05% | +103K | +14.1% | $36.80 | +24.8% |
| 30 | MBX | MBX BIOSCIENCES INC | Healthcare | 515,279.0 | $28.4M | 0.98% | +336K | +188.0% | $55.20 | +20.9% |
| 31 | — | PALISADE BIO INC | — | 13,063,687.0 | $27.3M | 0.94% | NEW | — | $2.09 | — |
| 32 | PHVS | PHARVARIS N V | Healthcare | 730,907.0 | $25.3M | 0.87% | +29K | +4.1% | $34.58 | +7.0% |
| 33 | ORGO | ORGANOGENESIS HLDGS INC | Healthcare | 10,140,951.0 | $24.6M | 0.85% | +55K | +0.6% | $2.43 | -28.0% |
| 34 | SUPN | SUPERNUS PHARMACEUTICALS | Healthcare | 520,000.0 | $24.2M | 0.83% | NEW | — | $46.51 | -3.5% |
| 35 | PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | 1,003,000.0 | $22.6M | 0.78% | +843K | +526.9% | $22.58 | -6.7% |
| 36 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 709,000.0 | $22.2M | 0.76% | +259K | +57.6% | $31.26 | -18.5% |
| 37 | — | INHIBIKASE THERAPEUTICS INC | — | 10,875,000.0 | $22.1M | 0.76% | — | — | $2.03 | — |
| 38 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 1,179,618.0 | $22.0M | 0.76% | -440K | -27.2% | $18.65 | -3.9% |
| 39 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 375,572.0 | $21.5M | 0.74% | -275K | -42.3% | $57.22 | +14.7% |
| 40 | LIVN | LIVANOVA PLC | Healthcare | 254,957.0 | $21.0M | 0.72% | -328K | -56.2% | $82.23 | -2.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%